BPH Global Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 1.164x

BPH Global Ltd cash flow conversion efficiency. Based on the latest financial reports, BPH Global Ltd (BP8) has a cash flow conversion efficiency ratio of 1.164x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.03 Million ≈ $-727.20K USD) by net assets (AU$-883.01K ≈ $-624.78K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of BPH Global Ltd (2001–2026)

Cash flow conversion efficiency of BPH Global Ltd from 2001 to 2026. This chart illustrates how BPH Global Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BPH Global Ltd stock price for real-time trading data and today's change.

BPH Global Ltd Cash Flow Conversion Ratio Explained

BPH Global Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

BPH Global Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BPH Global Ltd ranked by their cash flow conversion efficiency. Also see BP8 market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Montero Mining and Exploration Ltd
V:MON
-0.134x
GRUPUL INDUSTRIAL ELECTROCONTACT S.A.
RO:ECT
N/A
Silver Castle Holdings Ltd
TA:SLCL
0.557x
Discovery Alaska Ltd
AU:DAF
-0.122x
Borqs Technologies Inc.
NASDAQ:BRQSF
N/A
Orexplore Technologies Ltd
AU:OXT
-0.404x
DIRECTA PLUS PLC LS-0025
F:88K
N/A
Cathedra Bitcoin Inc
V:CBIT
-0.068x

Annual Cash Flow Conversion Efficiency for BPH Global Ltd (2001–2026)

The table below shows the annual cash flow conversion efficiency of BPH Global Ltd from 2001 to 2026. Review BP8 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-06-30 AU$-883.01K
≈ $-624.78K
AU$-2.14 Million
≈ $-1.51 Million
2.418x +280.91%
2025-06-30 AU$-1.46 Million
≈ $-1.04 Million
AU$-929.81K
≈ $-657.90K
0.635x +143.22%
2023-06-30 AU$911.90K
≈ $645.22K
AU$-1.34 Million
≈ $-947.87K
-1.469x -164.66%
2022-06-30 AU$4.72 Million
≈ $3.34 Million
AU$-2.62 Million
≈ $-1.85 Million
-0.555x -167.29%
2021-06-30 AU$6.48 Million
≈ $4.58 Million
AU$-1.35 Million
≈ $-951.69K
-0.208x +87.69%
2020-06-30 AU$760.03K
≈ $537.77K
AU$-1.28 Million
≈ $-907.30K
-1.687x -295.36%
2019-06-30 AU$2.08 Million
≈ $1.47 Million
AU$-888.26K
≈ $-628.50K
-0.427x +67.16%
2018-06-30 AU$1.20 Million
≈ $849.55K
AU$-1.56 Million
≈ $-1.10 Million
-1.299x -650.01%
2017-06-30 AU$2.12 Million
≈ $1.50 Million
AU$-368.03K
≈ $-260.40K
-0.173x +25.38%
2016-06-30 AU$4.15 Million
≈ $2.94 Million
AU$-964.59K
≈ $-682.51K
-0.232x +94.32%
2015-06-30 AU$149.84K
≈ $106.02K
AU$-612.90K
≈ $-433.66K
-4.090x -4763.73%
2007-06-30 AU$67.97 Million
≈ $48.09 Million
AU$-5.72 Million
≈ $-4.04 Million
-0.084x -121.86%
2006-06-30 AU$67.48 Million
≈ $47.75 Million
AU$25.96 Million
≈ $18.37 Million
0.385x -14.36%
2004-06-30 AU$17.95 Million
≈ $12.70 Million
AU$8.06 Million
≈ $5.70 Million
0.449x -57.18%
2003-06-30 AU$12.64 Million
≈ $8.94 Million
AU$13.26 Million
≈ $9.38 Million
1.049x +1049.89%
2001-06-30 AU$11.29 Million
≈ $7.99 Million
AU$1.03 Million
≈ $728.79K
0.091x --

About BPH Global Ltd

AU:BP8 Australia Drug Manufacturers - Specialty & Generic
Market Cap
$21.65 Million
AU$30.60 Million AUD
Market Cap Rank
#29805 Global
#1704 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.02
All Time High
AU$2.05
About

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics… Read more